Education
About Us
Working with TipRanks
Follow Us
Akero Therapeutics Inc (DE:0K4)
FRANKFURT:0K4
Akero Therapeutics (0K4) Ownership Overview
3.55% Insiders
24.90% Mutual Funds
40.02% Other Institutional Investors
12.18% ETFs
19.35% Public Companies and
Individual Investors
The ownership structure of Akero Therapeutics (DE:0K4) stock is a mix of institutional, retail, and individual investors. Approximately 77.09% of the company’s stock is owned by Institutional Investors, 3.55% is owned by Insiders, and 19.35% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 07, 2025 | Graham G. Walmsley Director | xxxxxxxxxxxxx | $9600000 |
| Dec 12, 2024 | Patrick Lamy Svp, Commercial Strategy | xxxxxxxxxxxxx | $28481 |
| Dec 12, 2024 | xxxxxxxxxxxxx | $77067 | |
| Dec 12, 2024 | Andrew Cheng President & Ceo,director | xxxxxxxxxxxxx | $241855 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $10570681 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $32983169 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,401,168 | Institution | 5.86% | 216,220,582 | |
| 3,515,768 | Institution | 4.68% | 172,722,650 | |
| 3,051,350 | Institution | 4.06% | 149,906,723 | |
| 2,901,480 | Institution | 3.86% | 142,543,909 | |
| 2,211,553 | Institution | 2.94% | 108,649,176 | |
| 1,814,384 | Institution | 2.41% | 89,137,057 | |
| 1,185,592 | Institution | 1.58% | 58,245,764 | |
| 1,097,082 | Institution | 1.46% | 53,897,444 | |
| 1,002,168 | Insider | 1.33% | 49,234,510 | |
| 921,588 | Institution | 1.23% | 45,275,775 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,401,168 | Institution | 5.86% | 216,220,582 | |
| 2,901,480 | Institution | 3.86% | 142,543,909 | |
| 2,211,553 | Institution | 2.94% | 108,649,176 | |
| 1,814,384 | Institution | 2.41% | 89,137,057 | |
| 766,471 | Institution | 1.02% | 37,655,187 | |
| 634,874 | Institution | 0.85% | 31,190,090 | |
| 608,731 | Institution | 0.81% | 29,905,737 | |
| 549,964 | Institution | 0.73% | 27,018,631 | |
| 436,978 | Institution | 0.58% | 21,467,855 | |
| 375,777 | Institution | 0.50% | 18,461,172 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Akero Therapeutics Inc (DE:0K4)?
According to the latest TipRanks data, approximately 40.02% of the company's stock is held by institutional investors, 3.55% is held by insiders, and 19.35% is held by retail investors.
What percentage of Akero Therapeutics Inc (DE:0K4) stock is held by institutional investors?
According to the latest TipRanks data, approximately 40.02% of Akero Therapeutics Inc (DE:0K4) stock is held by institutional investors.
What percentage of Akero Therapeutics Inc (DE:0K4) stock is held by retail investors?
According to the latest TipRanks data, approximately 19.35% of Akero Therapeutics Inc (DE:0K4) stock is held by retail investors.
Who owns the most shares of Akero Therapeutics Inc (DE:0K4)?
VANGUARD SPECIALIZED FUNDS owns the most shares of Akero Therapeutics Inc (DE:0K4).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.